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Endometriosis is defined as the presence of endometrial-like tissue (glands or stroma) out-
side the uterus, which induces a chronic inflammatory reaction. Although endometriosis
impairs fertility, it does not usually completely prevent conception. The question of evi-
dence based-medicine guidelines in endometriosis-associated infertility is weak in many
situations. Therefore, we will highlight in this issue where the challenges are.
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INTRODUCTION
Ovulatory disorders, tubal obstruction, and semen abnormalities
account in nearly 75% of infertile couples. The remaining 25% of
infertility is due to endometriosis (in up to 40% of the cases) or
classified as unexplained (Table 1) (1).
Endometriosis is defined as the presence of endometrial-
like tissue (glands or stroma) outside the uterus, which induces
a chronic inflammatory reaction (2). The exact prevalence of
endometriosis is unknown but estimated to range from 2 to 10%
in women of childbearing age. Its prevalence rises up to 50% in
women with infertility (3).
In women with endometriosis, there is a reduced monthly
fecundity rate (2–10%) compared with fertile couples (15–20%)
(4). Although endometriosis impairs fertility, it does not usually
completely prevent conception. The question of evidence based-
medicine guidelines in endometriosis-associated infertility is weak
in many situations. Therefore, we will highlight in this issue where
the challenges are.
ENDOMETRIOSIS AND REPRODUCTION
The fecundity in the control groups of women with endometrio-
sis attempting to become pregnant naturally was approximately
half that of a group with pure unexplained infertility without
endometriosis (5). A large multicentric prospective study (6)
showed a reduced fecundity in women with minimal endometrio-
sis. Although there is a substantial evidence for relationship
between endometriosis and infertility, a causal relationship has
not been established. The mechanisms for endometriosis-related
infertility are not fully understood and seem to be different in
different stages of endometriosis.
MILD OR MINIMAL ENDOMETRIOSIS AND INFERTILITY
The mechanisms underlying reproductive failure are subtle and
remain controversial, especially in cases where ovaries and fal-
lopian tubes are normal. However, the following effects on
reproduction could be noticed:
• A toxic effect on gametes, embryos, and impairment of tubal
motility: endometriotic implants secrete pro-inflammatory
cytokines (IL-1β, IL-8, IL-6, and TNF α), estradiol, and proges-
terone which attract macrophages, vascular endothelial growth
factor (VEGF), and interleukin-8, thus creating an inflammatory
state impairing fertility (7, 8).
• An abnormal follicular environment, high in cytokines (9).
• Increased rate of apoptosis in granulosa cells (10, 11).
• An enhanced ability to phagocytose sperm by peritoneal
macrophages (12).
• A reduced rate of fertilization in women undergoing ART
(13–17).
• An impairment of implantation rates and endometrial recep-
tivity owing to the local inflammatory state and to an excessive
production of antibodies to endometrial antigens (18).
MODERATE TO SEVERE DISEASE AND REPRODUCTION
In addition to above mentioned factors there is (19):
• An impairment of oocyte release owing to pelvic adhesions and
endometriomas.
• An impairment of tubal transport.
• A blockage of sperm migration.
MEDICAL VERSUS SURGICAL TREATMENT: WHAT IS THE
BEST CHOICE ANDWHAT COMES FIRST?
The current debate is about whether it is necessary to medically
treat, operate, and/or combine both treatments in infertile women.
MEDICAL TREATMENT INDICATION IN REPRODUCTIVE MEDICINE
In case of spontaneous conception, Hughes et al. (20) showed,
through a large meta-analysis that ovarian suppression [oral
contraceptive pill (OCP), GnRH agonists, Medroxyproges-
terone acetate, Danazol] is not recommended for women with
endometriosis and wishing to conceive, since there is no difference
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Table 1 | Frequency of diseases associated with infertility (1).
Diseases Percentage
Female partner Ovulatory disorders 25–27
Endometriosis 5–15
Pelvic adhesions 12
Tubal occlusion 11
Other tubal abnormalities 11
Hyperprolactinemia 7
Male partner Abnormal semen analysis 25
Unexplained 17
Other 4
in spontaneous pregnancy or live births rates when compared to
placebo or no treatment.
Since surgery may not remove microscopic disease, hormonal
treatments have been used to suppress disease and to pre-
vent recurrence. A meta-analysis comparing surgery plus hor-
monal treatment (GnRH agonists, Danazol, Medroxyprogesterone
acetate) versus surgery plus placebo or no treatment showed no
difference in pregnancy rates.
In infertile women with endometriosis, the Guideline Devel-
opment Group (GDG) recommendation to clinicians is not
to prescribe adjunctive hormonal treatment before surgery to
improve spontaneous pregnancy rates, as suitable evidence is lack-
ing (19). It is important to realize that clinicians should not
withhold hormonal treatment for symptomatic women in the
waiting period before undergoing surgery or medical assisted
reproduction (19).
SURGICAL TREATMENT
Surgery’s aim is to remove macroscopic endometriosis implants
and restore normal pelvic anatomy. However, surgery may not be
able to completely restore pelvic anatomy or to stop inflammatory
process. Hence, it is important to weigh up benefits versus harm
of surgical procedure. Laparoscopy is preferred to laparotomy
because of advantages of minimal tissue damage, of magnification,
of faster recovery, and shorter hospital stay (21).
Is there a benefit of surgical treatment of stage I–II of endometriosis
and successful pregnancy rate?
Several studies demonstrated that, in infertile women with
endometriosis stage I/II of the American Fertility Soci-
ety/American Society for Reproductive Medicine (AFS/ASRM),
clinicians should perform operative laparoscopy (excision or
ablation of endometriosis lesions) including adhesiolysis, rather
than performing diagnostic laparoscopy only, since there is
a positive effect in regards to live birth and ongoing preg-
nancy at 20 weeks of amenorrhea (OR 1.64; 95% CI 1.05–2.57)
(19, 22).
According to ESHRE guidelines, and concerning management
of women with stage I–II of endometriosis, clinicians may consider
CO2 laser vaporization of endometriosis, instead of monopo-
lar electro-coagulation, since laser vaporization is associated with
higher cumulative spontaneous pregnancy rates (23).
Is there a benefit of surgical treatment of stage III–IV of
endometriosis and successful pregnancy rate?
There is no randomized controlled trial or meta-analysis to assess
whether surgery is positively effective or not on pregnancy rates in
moderate to severe endometriosis. The lack of randomized trials
or meta-analysis is not due to lack of research effort but to the
unethical aspect of such studies that is to do nothing to a patient
with stage III or IV endometriosis who is already under anesthesia
could be ethically unacceptable.
There are many non-randomized uncontrolled studies with
results varying from a postoperative pregnancy rate of 30–67%
(24). Three high quality prospective cohort-studies (19, 25)
showed crude spontaneous pregnancy rates of 57–69% (mod-
erate endometriosis) and 52–68% (severe endometriosis) after
laparoscopic surgery, which are much higher than the crude spon-
taneous pregnancy rates of 33% (moderate) and 0% (severe)
after expectant management reported in a study by Vercellini
et al. (19).
There is conflicting evidence to determine whether removal of
recto-vaginal lesions improves spontaneous pregnancy rates (2).
Moreover, such a kind of aggressive surgery is accompanied by
a high rate of complications (26, 27).The discrepancy in results
between the different stages of the disease shows no correlation
between the AFS classification and the outcomes in terms of fertil-
ity. Thus it is necessary to define a phenotypic profile of the lesions
(28). The major benefit of surgery is achieved shortly after the first
attempt because severe peri-ovarian adhesions will generally recur
and will limit tubal pick-up of the ovum. If initial surgery does not
result in pregnancy, subsequent surgical procedures are not likely
to be effective for increasing fecundability.
A systematic review demonstrated a halving of pregnancy rates
after re-operative surgery compared with first line surgery (22%
for repetitive surgery versus 40% after primary surgery) (29).
The decision for re-operative surgery versus IVF must be made
on symptoms, the presence of complex cysts requiring histolog-
ical diagnosis, age, ovarian reserve, male factor infertility, and
availability of skilled surgeons (24).
HOW SHOULD WE BEHAVE WITH OVARIAN ENDOMETRIOMA IN CASE
OF INFERTILITY?
According to the ESHRE Guideline (19) in infertile women with
ovarian endometrioma of >3 cm in size, surgeons should per-
form excision of endometrioma capsule instead of ablative surgery
that is drainage and electro-coagulation of the endometrioma wall
since it increases the spontaneous postoperative pregnancy rate.
Excision of endometriomas involves the opening of the cyst
(using scissors or electrosurgical or laser energy). After identi-
fying the plane of cleavage between the cyst wall and ovarian
tissue, the cyst wall is then excised or “stripped away” by applying
opposite bimanual traction and counter actin with two grasping
forceps. The ovarian edges could be sutured or inverted by light
application of bipolar coagulation or kept as they are. Ablative
surgery also involves the opening and drainage or fenestration
(making a window in the wall of the cyst) of the endometrioma,
followed by the destruction of the cyst wall using either elec-
trosurgical current, cutting or coagulating current or a form of
laser energy.
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A study by Donnez et al. (30) showed that a combined technique
of excisional (cystectomy) and Laser ablative surgery without ovar-
ian suture could be the best compromise for sparing ovarian
reserve.
The ESHRE guideline (19) for the management of women
with endometriosis, recommended that clinicians should coun-
sel infertile women with endometrioma regarding the risks of
reduced ovarian function after surgery and the possible loss of the
ovary. The decision to proceed with surgery should be considered
carefully if woman has had previous ovarian surgery.
IS THERE ANY ASSOCIATION BETWEEN ENDOMETRIOMA AND RISK OF
OVARIAN CANCER?
The ESHRE’s GDG concluded that there is no evidence that
endometriosis causes cancer, though some cancers are slightly
more common in women with endometriosis such as non-
Hodgkin’s lymphoma and ovarian cancer (19). A very large study
(31) showed a higher risk of histological subtypes of ovarian cancer
in case of endometriosis. Self-reported endometriosis was associ-
ated with significantly increased risk of clear cell ovarian cancer
(OR 3.05, 95% CI 2.43–3.84), low-grade serous ovarian cancer
[OR 2.11, 95% CI 1.39–3.2 (p< 0.0001)], and endometrial inva-
sive ovarian cancer [OR 2.04, 95% CI 1.67–2.48 (p< 0.0001)].
Clinicians should be aware of this increased risk and future efforts
should be focused on understanding the mechanisms that might
lead to malignant transformation of endometriosis so as to help
identify subsets of women at increased risk of ovarian cancer.
DOES ENDOMETRIOSIS IMPACT ART OUTCOMES?
Minimal or mild endometriosis alters the outcome of controlled
ovarian hyperstimulation (COH) in intra-uterine insemination
(IUI) (32–38) with up to 30% reduction in pregnancy rate
(Figure 1).
Two randomized controlled trials (24) supported the view that
COH–IUI is better than no treatment for endometriosis. Tum-
mon and co-workers found that cumulative live birth rate was
fivefold higher following COH–IUI. In a systematic review and
meta-analysis about endometriosis and IVF, Harb et al. (39) found:
• There is 7% reduction in fertilization rate in stage I/II
endometriosis, and no difference in fertilization rate for stage
FIGURE 1 | Outcomes of COH–IUI in minimal or mild endometriosis
(33).
III/IV endometriosis when compared to controls (IVF in women
without endometriosis).
• There is no difference in implantation rate for stage I/II
endometriosis when compared to controls, and 21% reduction
in implantation rate for stage III/IV endometriosis.
• No difference in clinical pregnancies for stage I/II when com-
pared to controls however there is 21% reduction in clinical
pregnancies for stage III/IV endometriosis compared to controls.
• There is no statistical difference in live birth for all stage’s
endometriosis.
Concerning ovarian endometriosis, since they are dealing with
all stages of endometriosis, studies show different opinions, some
found no impact (40–42), and others found a decreased response
but no impact on IVF outcome (15, 16, 43–45) and finally
some others found a decreased IVF outcome depending on the
endometriosis severity (19, 46, 47).
Barnhart et al., in a meta-analysis of 22 observational stud-
ies, showed that women with endometriosis have poorer IVF
outcomes (the number of oocytes collected and the number of
fertilized oocytes) than women with tubal infertility (OR 0.56;
95% CI 0.4–0.7). Besides, women with more severe disease had
worse outcomes than women with minimal-mild endometriosis
(19).
More and more papers are reporting a reduction in ovarian
reserve after laparoscopic surgery for endometriomas. Indeed, very
frequently, normal ovarian tissue is excised with the endometri-
oma wall. Preservation of ovarian tissue (48), oocytes, or embryos
cryopreservation (emergency IVF) (49) should be considered in
all patients at serious risk of future fertility impairment as in case
of cancers undergoing cytotoxic chemotherapies.
DOES MEDICAL TREATMENT SHOULD BE BEFORE OR AFTER SURGERY
IN PATIENT WITH ENDOMETRIOSIS UNDERGOING ART?
In ART, the pre-treatment with GnRH agonists significantly
increased live birth rate compared with no pre-treatment (OR
9.19; 95% CI 1.08–78.22) (50). The very wide confidence interval
around the point estimate caused some doubt on the strength of
the conclusions.
A study (51) suggested that ART outcomes following OCP pre-
treatment in women with endometriosis are comparable with the
outcomes of age-matched controls without endometriosis, thus
showing a positive effect.
In one hand, in infertile women with stage I/II endometrio-
sis, an IUI with gonadotropins controlled ovarian stimulation
(COS) should be performed, instead of expectant management
and instead of IUI alone as it increases respectively 5.6 and 5.1
times live birth rates. On the other hand, clinicians may con-
sider performing IUI with COS within 6 months after surgical
treatment, since pregnancy rates are similar to those achieved in
unexplained in unexplained infertility (19).
However, it is less clear whether surgery for minimal – mild
endometriosis prior to COH–IUI improves the success rate (24).
The influence of endometriosis on the success rate of IVF/ICSI
in not unequivocal. Barnhart et al. found that pregnancy rates after
IVF/ICSI were lower in patients with stage III/IV endometrio-
sis as compared to those with tubal factor (19). However, some
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Table 2 | Risk and benefits of observational and surgical management
of endometriomas (19).
Observational Surgery
BENEFITS
Avoid surgery Exclude malignancy
Low FSH doses Relieve symptoms
Increased E2 Reduce the risk of cyst complications
Increased follicles Facilitate transvaginal access to ovarian
follicles
RISKS
Pain Ovarian failure because of destruction
of normal tissue
No histological diagnosis Reduced number of egg collected
Pelvic infection following oocyte
retrieval
Risks of surgery
large databases (The society for assisted reproductive technology –
SART – and the human fertilization and embryology authority)
noted that endometriosis does not adversely affect pregnancy
rates. It seems that GnRH antagonist protocol is not inferior to
GnRH agonist protocol in women with stage I/II endometriosis
and endometrioma (19). The GDG of the ESHRE recommends
the use of ART for infertility associated with endometriosis, espe-
cially if tubal function is compromised or if there is male factor
infertility and/or other treatments have failed (19).
In a Cochrane review, it appears that down-regulation for
3–6 months with GnRH agonists in women with endometrio-
sis increases the odds of clinical pregnancy by more than
fourfold (50).
The benefit of surgery for endometriomas prior to IVF is still
uncertain (Table 2). A number of concerns have been raised as
arguments for surgery. However, the available evidence appears to
alleviate these concerns:
• There is no reduced ovarian responsiveness with COH in women
or ovaries with endometriosis (24).
• There is no risk of growth or rupture of endometriomas with
COH (24).
• To date, there are no studies that proved an increased risk of
abscess formation following oocyte retrieval in women with
endometriomas (24). Clinicians may use antibiotic prophylaxis
at the time of oocyte retrieval, although the risk of abscess is low
(19).
• Ovarian surgery seems to reduce the number of oocytes
retrieved, to reduce the peak estradiol levels and to increase
total FSH requirement. It has been reported that ovarian surgery
can lead to ovarian failure in 13% of the cases (52, 53). Beside
the later, in infertile women, resection of endometriomas larger
than 3 cm does not seem to improve pregnancy rates (19,
54–56), thus the GDG according to ESHRE guidelines rec-
ommended to consider cystectomy prior to ART to improve
endometriosis-associated pain or the accessibility of follicles
22. The decision to proceed with surgery should be considered
carefully if women have had previous ovarian surgery.
• Concerning deep endometriosis, there is no evidence to rec-
ommend performing surgical excision of deep nodular lesions
prior to ART, to improve reproductive outcomes. However, these
women often suffer from pain, requesting surgical treatment
(19, 55).
• ART treatments do not seem to increase the recurrence rate of
endometriotic lesions or symptoms (19).
CONCLUSION
Endometriosis is a common disease in infertile women. It can
affect fertility in many ways and at different levels. Medical
treatment of endometriosis does not improve spontaneous preg-
nancy rates, whereas there is evidence that surgery is beneficial
in minimal-mild endometriosis. There is controversial evidence
regarding removal of endometriomas owing to the potential
impact on ovarian reserve, but there are benefits of this surgery
such as pain relief.
Other RCT are required to assess the potential effects of aggres-
sive surgery and re-operative procedures. ART improves preg-
nancy rates as compared with no treatment, but the pregnancy
rates remain lower than that of endometriosis-free women. Med-
ical, surgical, and ART treatments do not need to occur separately
and many women may benefit from a combination of these three
approaches.
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